CareDx Presents Data Linking Elevated AlloSure Kidney to Higher Graft Risk
CareDx reported studies at ASN Kidney Week 2026 linking elevated AlloSure Kidney dd-cfDNA to nearly 3-fold higher risk of adverse graft outcomes in patients with borderline rejection or TCMR.